Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 Jul;77(1):F32-5.
doi: 10.1136/fn.77.1.f32.

Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants

Affiliations
Clinical Trial

Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants

V G Prabhu et al. Arch Dis Child Fetal Neonatal Ed. 1997 Jul.

Abstract

Aims: To compare the effects of a single dose of frusemide administered either intravenously or by nebulisation on pulmonary mechanics in premature infants with evolving chronic lung disease.

Methods: The effect of frusemide on pulmonary mechanics was studied at a median postnatal age of 23 (range 14-52) days in 19 premature infants at 24 to 30 weeks gestational age, who had been dependent on mechanical ventilation since birth. Frusemide (1 mg/kg/body weight) was administered, in random order, intravenously and by nebulisation, on two separate occasions 24 hours apart. Pulmonary function studies were performed before and at 30, 60, and 120 minutes after administration of frusemide. Urine was collected for six hours immediately before and for six hours after administration of frusemide.

Results: Nebulised frusemide increased the tidal volume 31 (SE 11.5)% and compliance 34 (SE 12)% after two hours, whereas no change in either was noted for up to two hours after intravenous frusemide administration. Neither intravenous nor nebulised frusemide had any effect on airway resistance. Six hour urine output increased from a mean (SE) of 3.3 (0.4) ml/kg/hour to 5.9 (0.8) ml/kg/hour following intravenous frusemide administration while nebulised frusemide had no effect on urine output. Urinary sodium, potassium, and chloride losses were also significantly higher after intravenous frusemide, whereas nebulised frusemide did not increase urinary electrolyte losses.

Conclusion: Single dose nebulised frusemide improves pulmonary function in premature infants with evolving chronic lung disease without adverse effects on fluid and electrolyte balance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Per cent changes from baseline values in tidal volume, compliance, and airway resistance after intravenous and nebulised frusemide administration. Bold line represents intravenous, and shaded line, nebulised route. Data are mean (SE) B= before frusemide administration.

References

    1. J Pediatr. 1978 Jun;92(6):982-4 - PubMed
    1. J Pediatr. 1994 Dec;125(6 Pt 1):976-9 - PubMed
    1. J Pediatr. 1981 Mar;98(3):476-9 - PubMed
    1. Clin Perinatol. 1982 Oct;9(3):593-611 - PubMed
    1. Pediatrics. 1984 Jul;74(1):37-44 - PubMed

MeSH terms